Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Coxsackie viral infection, Herpes virus infection, Lyme disease
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Unknown
Diagnostic Lab Data:
CDC 'Split Type': WAES1608IRL003060
Write-up:Information has been received from Sanofi Pasteur MSD (SPM) on 04-AUG-2016. This case was received from RA (Ref no. IE-HPRA-2016-027321) on 02-AUG-2016. Initial case was received from a consumer/other non-health professional which concerns a 13-year-old female adolescent patient received GARDASIL, (batch number unknown), dose 1 (route of administration: intramuscular) on 01-OCT-2010, GARDASIL, (batch number unknown), dose 2 (route of administration: intramuscular) on 01-OCT-2011. Concomitant medications: None. Medical history/concurrent conditions: None reported. The patient experienced Chronic Lyme''s Disease, Active Coxsackie Virus and Active Herpes Virus Type 1 on 01-OCT-2010. The reporter added that the patient cannot leave bed for days and can''t live life. Corrective treatment: None. The reporter added that the patient is struggling from day to day. The patient''s outcome was reported as Not Recovered/Not Resolved. The reporter assessed the causal relationship: between Lyme disease, Coxsackie viral infection, Herpes simplex type 1 and GARDASIL as Unknown.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166